Enoxaparina Rovi

Enoxaparina Rovi is a biosimilar low-molecular-weight heparin (LMWH) used to prevent and treat deep vein thrombosis and pulmonary embolism. The product is developed and manufactured by Laboratorios Farmacéuticos Rovi, a prominent Spanish pharmaceutical group.

Laboratorios Rovi maintains full ownership of this brand, handling the entire lifecycle from research and development to manufacturing at its specialized facilities in Spain. The company is a key global player in the production of low-molecular-weight heparins and serves as a major contract manufacturing organization for various international pharmaceutical products. In Italy, the product is distributed through the group's local subsidiary, Rovi Pharma Italia S.r.l.